In vitro fusion of endocytic vesicles is inhibited by cyclin A-cdc2 kinase.

AUTOR(ES)

Woodman, P G

RESUMO

Receptor-mediated endocytosis and recycling are inhibited in mitotic mammalian cells, and previous studies have shown that inhibition of endocytic vesicle fusion in vitro occurs via cyclin B-cdc2 kinase. To test for the ability of cyclin A-cdc2 kinase to inhibit endocytic vesicle fusion, we employed recombinant cyclin A proteins. Addition of cyclin A to interphase extracts activated a histone kinase and markedly reduced the efficiency of endocytic vesicle fusion. By a number of criteria, inhibition of fusion was shown to be due to the action of cyclin A, via the mitosis-specific cdc2 kinase, and not an indirect effect through cyclin B. Two-stage incubations were used to demonstrate that at least one target of cyclin A-cdc2 kinase is a cytosolic component of the fusion apparatus. Reconstitution experiments showed that this component was also modified in mitotic cytosols and was unaffected by N-ethyl maleimide treatment.

Documentos Relacionados

• Disassembly of in vitro formed lamin head-to-tail polymers by CDC2 kinase.
• A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase.
• Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase.
• Fusion between endocytic vesicles in a cell-free system.
• Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase.